ADELAIDE BIOMED CITY IS THE HOME OF SOUTH AUSTRALIA’S MOST TALENTED PEOPLE WHOSE IDEAS AND ENTREPRENEURIAL DRIVE TRANSFORM THE FUTURE OF HEALTH WITH WORLD-FIRST SOLUTIONS TO UNMET MEDICAL NEEDS.
At Adelaide Biomed City, researchers, clinicians, and students work together within our universities, medical research institutes and academic teaching hospitals, with world-class infrastructure interfacing with entrepreneurs and leading industry players to collaborate, create and commercialise world-first innovations.
Adelaide Biomed City’s goal is to make South Australia the best place in Australia for biomedical researchers, healthcare professionals, industry partners and governments to take on the health challenges of tomorrow – today.
Adelaide BioMed City (ABMC) is a $4.2 billion health innovation and translation district comprised of world class universities, medical research institutes and companies, that cluster and connect with entrepreneurs, start-ups, small and medium-sized local enterprises, multinational corporations, business incubators and accelerators.
ABMC leverages its strong local, national, and global connections, to promote South Australia’s unique biomedical strengths and attract the investment, talent, collaborations and partnerships vital to growing and sustaining our healthcare industry.
Modelled on the best practices of innovation districts around the world, ABMC provides the foundation for ground-breaking health innovations to flourish. Within its world class infrastructure and facilities, ABMC focuses on bringing together the best people to discover, collaborate and commercialise transforming technologies and businesses.
The cutting-edge innovation taking place within ABMC is changing the face of the world’s most significant healthcare challenges and is delivering improved healthcare for our South Australian community and globally.
“TOGETHER,WE WILL TRANSFORM HEALTHCARE”
Interconnectivity, Colocation and Convergent Technologie
Adelaide BioMed City is part of the South Australian ecosystem of Innovation Districts that include the Tonsley Innovation District and Lot Fourteen.
Inter-district connectivity is a key priority for ABMC to foster collaboration and drive innovation, growth, and economic return.
Inter-district connectivity, collaboration and knowledge transfer allows ABMC to leverage SA’s acknowledged strengths in emerging and convergent technologies for the benefit of healthcare. These technologies, coupled with ABMC’s excellence in biomedical research are increasing productivity, developing new-to-world products and services. Working together, South Australia’s Innovation Districts are developing solutions for complex multi-disciplinary problems, delivering improved, more affordable healthcare.
Importantly, co-location of infrastructure and expertise supports genuine collaboration, which, on the global stage, has proven to drive productivity, economic growth, social prosperity, sovereignty and industry resilience. ABMC’s proximity to Lot Fourteen, with their focus on big data, artificial intelligence (AI) and digital health, and to Tonsley, with their focus on modern manufacturing, assistive technologies and MedTech, perfectly positions South Australia to significantly impact health innovation and improved patient care.
Harnessing SA’s Technology Strengths for Biomedical Excellence
Technology convergence is driving the growth of the global therapeutic, diagnostic and medtech industries. Combining technologies such as artificial intelligence (AI), digital health, wearable devices and data analytics, has exponentially increased the development of new high-tech medical devices and services. Using bioinformatics, AI and machine learning together with South Australia’s renown and well-curated health data enables us to explore new approaches to improving health outcomes.
By promoting inter-district connectivity, collaboration and a focus on multi-disciplinary projects, ABMC is supporting and growth of convergent technologies within South Australia.
“TOGETHER, WE TURN COURAGEOUS IDEAS INTO BRILLIANT HEALTHCARE SOLUTIONS”.
ABMC’s approach is helping South Australia take a leading role in Australia’s healthcare innovation.
Technologies such as robotics, augmented reality/virtual reality, AI, imaging, wearable devices and therapeutics provide a new opportunity to address some of society’s greatest health challenges such as ageing, obesity, cancer, declining mobility and mental health. A chance to elevate standard of care through personalised approaches.
This convergence of technologies also drives convergence of sectors in the quest for innovative solutions. Health, the arts, and mathematical sciences can effectively combine in the realm of immersive technologies to present new clinical interventions in mental health, performance medicine and creative experiences.
Continuing infrastructure development within the ABMC district, like the seminal Trinity City project, supports this convergence of technologies and sectors by providing opportunities for multi-disciplinary teams, innovation district support services such as commercialisation and IP professionals, and industry all within the same best-of class infrastructure. These assets attract global leaders and health industry looking to benefit from South Australia’s strengths in clinical trials, curated health data and convergent technologies.
ABMC sees the totality of this convergence providing many opportunities in the clinical setting, leading cell therapies, vaccines, therapeutics, surgical robots, wearable devices and artificial limbs and joints, to interface with pathology services such as genomics, spatial transcriptomics and immunoprofiling to infer previously unmatched clinical information for disease diagnosis, monitoring and prognosis.
It’s a transforming time for the health and medical innovation sector in South Australia. Research excellence and clinical care, coupled with a network of rapidly expanding best in class innovation districts provides the perfect platform for South Australia to play a significant role in global health innovation. ABMC is a key part of South Australia’s innovation community, bringing economic benefits and job growth to the state, and most significantly, providing improved outcomes for patients locally, nationally and globally.
“TOGETHER, WE GO FURTHER”.